Outcomes and clinicopathologic characteristics associated with disseminated tumor cells in bone marrow after neoadjuvant chemotherapy in high-risk early stage breast cancer: the I-SPY SURMOUNT study-Reference-Cited by-同舟云学术

Outcomes and clinicopathologic characteristics associated with disseminated tumor cells in bone marrow after neoadjuvant chemotherapy in high-risk early stage breast cancer: the I-SPY SURMOUNT study

Published:2023-01-23 Issue:2 Volume:198 Page:383-390
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Magbanua Mark Jesus M.^ORCID,van ‘t Veer Laura,Clark Amy S.,Chien A. Jo,Boughey Judy C.,Han Hyo S.,Wallace Anne,Beckwith Heather,Liu Minetta C.,Yau Christina,Wileyto E. Paul,Ordonez Andrea,Solanki Tulasi I.,Hsiao Feng,Lee Jen Chieh,Basu Amrita,Brown Swigart Lamorna,Perlmutter Jane,Delson Amy L.,Bayne Lauren,Deluca Shannon,Yee Stephanie S.,Carpenter Erica L.,Esserman Laura J.,Park John W.,Chodosh Lewis A.,DeMichele Angela

Funder

University of Pennsylvania Health System

Breast Cancer Research Foundation

Cancer Cell Mapping Initiative Training Fellowship

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10549-022-06803-0.pdf

Reference25 articles.

1. Abravanel DL, Belka GK, Pan TC, Pant DK, Collins MA, Sterner CJ, Chodosh LA (2015) Notch promotes recurrence of dormant tumor cells following HER2/neu-targeted therapy. J Clin Invest 125:2484–2496. https://doi.org/10.1172/JCI74883